Frank Verwiel has sold NTLA and made no open-market buys since Jun 2024
Director at Intellia Therapeutics, Inc.
SEC CIK 0001545794 · Filings on SEC.gov ↗
$0Bought
$38KSold
NoneLast buy
Every filing
1 filing since Jun 2024, newest first
Filings come from SEC EDGAR. Not investment advice.